Antimicrobial Wound Dressings: Silver vs Iodine vs PHMB

Antimicrobial Wound Dressings: Choosing Between Silver, Iodine, and PHMB

Antimicrobial wound dressings are not interchangeable. Silver, iodine, and polyhexamethylene biguanide (PHMB) each deliver antimicrobial activity through fundamentally different mechanisms, with different spectra of activity, different cytotoxicity profiles, and different clinical scenarios where each performs best. Treating them as equivalent options and choosing based on habit or inventory availability means patients get suboptimal antimicrobial coverage for their specific wound presentation.

This comparison covers the three most commonly used antimicrobial dressing agents in wound care, with emphasis on the clinical decision points that differentiate them: mechanism of action, spectrum of activity, duration of use considerations, cytotoxicity thresholds, and the cost variables that wound care programs must factor into formulary decisions.

---

Silver Dressings: Broad Spectrum, Multi-Target

Mechanism

Ionic silver (Ag+) disrupts bacterial cells through multiple simultaneous targets -- cell wall integrity, protein denaturation, DNA replication interference, and electron transport chain disruption. This multi-target mechanism is why silver maintains effectiveness against organisms that have developed resistance to single-target antibiotics.

Silver dressings release ionic silver at the wound surface, where it interacts with bacteria in the wound fluid. The release kinetics vary significantly by product: nanocrystalline silver delivers rapid, high-concentration release, while silver-impregnated foams and alginates provide slower, sustained release.

Spectrum of Activity

Silver is broad-spectrum, effective against gram-positive bacteria (including MRSA), gram-negative bacteria (including Pseudomonas aeruginosa), yeasts, and fungi. In vitro studies demonstrate activity against VRE, Acinetobacter, and biofilm-forming organisms, though biofilm penetration is limited compared to some alternative agents.

Duration and Cytotoxicity

The primary limitation of silver dressings is duration-dependent cytotoxicity. At concentrations that kill bacteria, silver also damages fibroblasts, keratinocytes, and endothelial cells. Clinical guidelines recommend limiting continuous silver dressing use to 2--4 weeks, then reassessing.

If the wound shows clinical improvement after 2 weeks of silver, transition to a non-antimicrobial dressing. If no improvement is apparent, re-evaluate the antimicrobial strategy rather than extending silver indefinitely.

For a detailed guide on silver dressing types and selection, see silver dressings in wound care.

---

Cadexomer Iodine: Sustained Release with Debridement

Mechanism

Cadexomer iodine represents a significant advancement over traditional povidone-iodine solutions. The cadexomer (modified starch) matrix absorbs wound exudate and swells, gradually releasing elemental iodine as it expands. This sustained, low-concentration release is fundamentally different from the bolus cytotoxic delivery of povidone-iodine solution.

The cadexomer matrix also physically absorbs bacteria, debris, and exudate as it swells, providing a mild debridement effect that clears the wound surface while delivering antimicrobial activity.

Spectrum of Activity

Iodine is the broadest-spectrum antimicrobial agent available for wound care. It is effective against:

• Gram-positive and gram-negative bacteria (including MRSA, VRE, Pseudomonas)
• Fungi and yeasts
• Mycobacteria
• Spores
• Viruses

No clinically significant bacterial resistance to iodine has been documented, which is a meaningful advantage over silver, where resistance mechanisms (though rare) have been identified in laboratory settings.

Duration and Cytotoxicity

Cadexomer iodine's sustained-release mechanism delivers iodine at concentrations that are antimicrobial but below the cytotoxicity threshold that made povidone-iodine solution controversial. Multiple clinical studies demonstrate that cadexomer iodine does not impair granulation tissue formation when used as directed.

Duration considerations:

• Avoid in patients with thyroid disorders (Hashimoto's thyroiditis, Graves' disease) -- absorbed iodine can disrupt thyroid function
• Avoid in patients taking lithium -- iodine interferes with lithium metabolism
• Limit use in large wounds (>150 cm2) or extended therapy (>6 months) without monitoring thyroid function
• Contraindicated in patients with known iodine allergy

Unique Advantage: Slough Management

The combination of exudate absorption, bacterial trapping, and gentle debridement makes cadexomer iodine particularly effective for sloughy, critically colonized wounds. No other antimicrobial dressing category provides this combined effect.

---

PHMB: Low Cytotoxicity, High Tissue Compatibility

Mechanism

Polyhexamethylene biguanide (PHMB) is a synthetic polymer that binds to negatively charged bacterial cell membranes, disrupting membrane integrity and causing cell lysis. The mechanism is similar to chlorhexidine (also a biguanide) but with lower tissue toxicity at antimicrobial concentrations.

PHMB is available in wound care as solution (for irrigation), gel, and impregnated dressings (gauze, foam, and biocellulose matrices).

Spectrum of Activity

PHMB demonstrates activity against:

• Gram-positive bacteria (including MRSA)
• Gram-negative bacteria (including Pseudomonas, E. coli, Klebsiella)
• Yeasts (Candida species)
• Biofilm-forming organisms -- PHMB shows clinically meaningful biofilm disruption in vitro and in clinical studies

PHMB's biofilm activity is a distinguishing feature. Studies demonstrate that PHMB penetrates and disrupts established biofilms more effectively than ionic silver at clinically relevant concentrations.

Duration and Cytotoxicity

PHMB has the lowest cytotoxicity profile of the three agents compared here. The biocompatibility index (ratio of cytotoxicity to antimicrobial activity) favors PHMB over both silver and iodine. This means PHMB can be used at effective antimicrobial concentrations with minimal impairment of wound healing cells.

Clinical implication: PHMB is the antimicrobial agent best suited for extended use when ongoing antimicrobial coverage is needed beyond the 2--4 week window recommended for silver. Chronic wounds with persistent bioburden that require weeks to months of antimicrobial support are candidates for PHMB rather than extended silver exposure.

No significant drug interactions or systemic absorption concerns have been documented with PHMB wound dressings.

---

Head-to-Head Decision Framework

When to Choose Silver

• Acute infection with heavy bioburden -- silver's rapid, high-concentration release is best when fast bacterial kill is the priority
• Short-duration antimicrobial coverage -- post-debridement, post-surgical, or transitional use where 2--4 weeks of coverage is sufficient
• Wounds also needing strong exudate management -- silver-impregnated foams and alginates combine antimicrobial and absorption functions

When to Choose Cadexomer Iodine

• Sloughy, critically colonized wounds -- the combination of antimicrobial activity, exudate absorption, and gentle debridement is unique to cadexomer iodine
• Wounds with suspected multi-organism colonization -- iodine's unmatched breadth of spectrum covers organisms that silver and PHMB may miss
• Situations where resistance is a concern -- no documented resistance to iodine makes it the most resistance-proof option

When to Choose PHMB

• Extended antimicrobial therapy needed -- when chronic wounds require ongoing antimicrobial coverage beyond 4 weeks, PHMB's low cytotoxicity makes it the safest choice for long-term use
• Biofilm-driven wound healing failure -- PHMB's biofilm penetration and disruption capability makes it a first-line choice for wounds where biofilm is the suspected barrier to healing
• Wounds with fragile granulation tissue -- when the wound bed is actively granulating but still requires antimicrobial support, PHMB provides coverage without the cytotoxicity risk of silver

For clinical assessment of wound infection signs that guide antimicrobial dressing initiation, see the infection assessment framework.

---

Cost Considerations

Antimicrobial dressing costs vary significantly across the three agent categories:

Silver dressings -- generally the highest per-unit cost, particularly nanocrystalline silver products. The 2--4 week use limitation means total treatment cost is bounded, but the daily cost is substantial. Silver-impregnated foams and alginates cost less than nanocrystalline but more than standard non-antimicrobial versions of the same dressing type.

Cadexomer iodine -- moderate cost per application, but frequent changes (daily or every other day until the cadexomer is fully saturated) can accumulate. The debridement benefit may offset costs by reducing the need for separate debridement interventions.

PHMB -- generally the lowest per-unit cost of the three agents. Combined with the extended duration of use (lower cytotoxicity allows longer therapy), PHMB often represents the lowest total cost of antimicrobial therapy for chronic wounds requiring ongoing coverage.

For skin substitute application after antimicrobial wound bed preparation, the 2026 CMS reimbursement rate is $127.14 per square centimeter flat, making appropriate wound bed preparation with the right antimicrobial agent a critical step in the treatment pathway.

---

Key Takeaways

• Silver is best for short-term, high-intensity antimicrobial coverage -- rapid bacterial kill in acutely infected or heavily colonized wounds, but limit use to 2--4 weeks due to cytotoxicity to healing cells.
• Cadexomer iodine combines antimicrobial activity with debridement -- the only antimicrobial dressing that also absorbs slough and debris; broadest spectrum with no documented resistance; check thyroid and lithium contraindications.
• PHMB is the safest choice for extended antimicrobial therapy -- lowest cytotoxicity profile allows weeks-to-months of use; superior biofilm penetration makes it first-line for biofilm-driven chronic wound stalling.
• These agents are not interchangeable -- selecting based on wound presentation (acute vs chronic, biofilm vs planktonic, short-term vs long-term need) determines which agent delivers the best outcome.
• Cost analysis must include duration, not just per-unit price -- PHMB's lower unit cost combined with longer safe use duration often makes it the most economical choice for chronic wound antimicrobial management.